Evaluating insulin information provided on discharge summaries in a secondary care hospital in the United Kingdom

被引：5

作者：

Bain A. ^{[1
]}

Nettleship L. ^{[1
]}

Kavanagh S. ^{[2
]}

Babar Z.-U. ^{[1
,3
]}

机构：

[1] University of Huddersfield, School of Applied Sciences, Queensgate, Huddersfield

[2] Sheffield Teaching Hospital NHS Foundation Trust, Pharmacy Department, Herries Road, Sheffield

[3] University of Auckland, School of Pharmacy, Faculty of Medical and Health Sciences, Private Mail Bag, Auckland

来源：

Journal of Pharmaceutical Policy and Practice | / 10卷 / 1期

关键词：

Diabetes mellitus; Insulin; Medication errors; Patient discharge summaries;

D O I：

10.1186/s40545-017-0113-y

中图分类号：

学科分类号：

摘要：

Background: Prescribing errors at the time of hospital discharge are common and could potentially lead to avoidable patient harm, especially when they involve insulin, a high-risk medicine widely used for the treatment of diabetes mellitus. When information regarding insulin therapy is not sufficiently communicated to a patient's primary care provider, continuity of care for patients with diabetes may be compromised. The objectives of this study were to investigate the nature and prevalence of insulin-related medication discrepancies contained in hospital discharge summaries for patients with diabetes. A further objective was to examine the timeliness and completeness of relevant information regarding insulin therapy provided on discharge summaries. Methods: The study was undertaken at a large foundation trust hospital in the North of England, UK. A retrospective analysis of discharge summaries of all patients who were being treated with insulin and were included in the 2016 National Inpatient Diabetes Audit was conducted. Insulin regimen information provided on discharge summaries was scrutinised in light of available medical records pertaining to the admission and current national recommendations. Results: Thirty-three (79%) out of the 42 patients included in the study had changes made to their insulin regimen during hospital admission. Eighteen (43%) patients were identified as having an error or discrepancy relating to insulin on their discharge summary. A total of 27 insulin errors or discrepancies were identified on discharge, most commonly involving non-communication of an insulin dose change (n = 8) and wrong insulin device (n = 7). Seventeen issues relating to completeness of insulin information were identified, including the omission of the prescribed time of insulin administration (n = 10) and unexplained insulin dose change (n = 4). Two patients who had insulin-related errors identified on their discharge summaries were readmitted to hospital within 30 days of discharge due to poor diabetic control. Conclusions: This small-scale study demonstrates that errors and discrepancies regarding insulin therapy on discharge persist despite current insulin safety initiatives. Poorly communicated information regarding insulin therapy may jeopardise optimal glycaemic control and continuity of patient care. Insulin-related information should be comprehensively documented at the point of discharge. This is to improve communication across the interface and to minimise risks to patient safety. © 2017 The Author(s).

引用

共 33 条

[11] Hammad E.A., Wright D.J., Walton C., Nunney I., Bhattacharya D., Adherence to UK national guidance for discharge information: an audit in primary care, Br J Clin Pharmacol., 78, 6, pp. 1453-1464, (2014)
[12] Cresswell A., Hart M., Suchanek O., Young T., Leaver L., Hibbs S., Mind the gap: Improving discharge communication between secondary and primary care, BMJ Qual Improv Reports., 4, 1, (2015)
[13] Grimes T., Delaney T., Duggan C., Kelly J.G., Graham I.M., Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care, Ir J Med Sci, 177, 2, pp. 93-97, (2008)
[14] Lehnbom E.C., Raban M.Z., Walter S.R., Richardson K., Westbrook J.I., Do electronic discharge summaries contain more complete medication information? A retrospective analysis of paper versus electronic discharge summaries, Heal Inf Manag J, 43, 3, pp. 4-12, (2014)
[15] ISMP List of High-Alert Medications in Acute Care Settings, Inst Safe Medicat Pract, (2011)
[16] Safer administration of insulin. NHS., (2010)
[17] Smith W.D., Winterstein A.G., Johns T., Rosenberg E., Sauer B.C., Causes of hyperglycemia and hypoglycemia in adult inpatients, Am J Heal Pharm, 62, 7, pp. 714-719, (2005)
[18] Leech N.J., Johnson G., Nayar R., Nunez E., Macleod J., Tackling insulin safety using a multifaceted multidisciplinary regional approach first report from the north east regional insulin safety and knowledge (RISK) project, Heal Found, (2013)
[19] Cousins D., Rosario C., Scarpello J., Insulin, hospitals and harm: a review of patient safety incidents reported to the National Patient Safety Agency, Clinical Medicine: Journal of the Royal College of Physicians of London, 11, pp. 28-30, (2011)
[20] Rousseau M.-P., Beauchesne M.-F., Naud A.-S., Leblond J., Cossette B., Lanthier L., Et al., An Interprofessional qualitative study of barriers and potential solutions for the safe use of insulin in the hospital setting, Can J Diabetes, 38, 2, pp. 85-89, (2014)

← 1 2 3 4 →